Serious Adverse Events with Bevacizumab or Ranibizumab for Age-Related Macular Degeneration: Meta-analysis of Individual Patient Data-Reference-Cited by-同舟云学术

Serious Adverse Events with Bevacizumab or Ranibizumab for Age-Related Macular Degeneration: Meta-analysis of Individual Patient Data

Published:2017-09 Issue:5 Volume:1 Page:375-381
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

Maguire Maureen G.,Shaffer James,Ying Gui-shuang,Chakravarthy Usha,Berg Karina,Bragadóttir Ragnheiður,Decullier Evelyne,Huot Laure,Kodjikian Laurent,Martin Daniel F.,Reeves Barnaby C.,Rogers Chris A.,Schauwvlieghe Ann-Sofie M.E.,Schlingemann Reinier O.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference29 articles.

1. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

2. Ranibizumab versus verteporfin for neovascular age-related macular degeneration;Brown;N Engl J Med,2006

3. Identifying and eliminating the roadblocks to comparative-effectiveness research;Martin;N Engl J Med,2010

4. Ranibizumab and bevacizumab for neovascular age-related macular degeneration;Martin;N Engl J Med,2011

5. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: 2-year results;Martin;Ophthalmology,2012

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence-Based Use of Bevacizumab in the Management of Neovascular Age-Related Macular Degeneration;Ophthalmic Surgery, Lasers and Imaging Retina;2024-03

2. Intravitreal vascular endothelial growth factors hypertension, proteinuria, and renal injury: a concise review;Current Opinion in Nephrology & Hypertension;2021-11-08

3. Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab;Ophthalmology;2021-07

4. Cardiovascular Adverse Events With Intravitreal Anti–Vascular Endothelial Growth Factor Drugs;JAMA Ophthalmology;2021-06-01

5. Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion;Ophthalmology Retina;2020-06